More articles from AD II: Advanced Approaches

You have access
Effect of pre-processing on diagnostic performance of FDG PET using machine-learning for the detection of Alzheimer's disease: The Ishikawa Brain Imaging Study
Ichiro Matsunari, Miharu Samuraki, Junji Komatsu, Kenjiro Ono, Moeko Shinohara, Tsuyoshi Hamaguchi, Kenji Sakai, Masahito Yamada and Seigo Kinuya

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 249;
You have access
The first 5 minutes of F18-Florbetapir scans as an estimate of regional cerebral blood flow and comparison to F18-FDG
Michael Devous, Abhinay Joshi, Ian Kennedy, Michael Navitsky, Michael Pontecorvo, Daniel Skovronsky and Mark Mintun

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 247;
You have access
Utility of early phase PIB as a surrogate for cerebral blood flow measures (CBF)
Laura Ponto, David Moser, Yusuf Menda and Susan Schultz

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 246;
You have access
Efficacy and reliability of the visual assessment of 18F-florbetaben PET scans in the detection of beta-amyloid neuritic plaques in the brain
Osama Sabri, Ana Catafau, Henryk Barthel, Kenji Ishii, Christopher Rowe, James Leverenz, Schulz-Schaefer Walter, Marwan Sabbagh, Andrew Stephens and John Seibyl

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 244;
You have access
Early β-amyloid PET images are a valuable surrogate biomarker of neuronal injury in dementia patients
Solveig Tiepolt, Swen Hesse, Marianne Patt, Julia Luthardt, Matthias Schroeter, Hermann-J Gertz, Karl Hoffmann, Osama Sabri and Henryk Barthel

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 248;
You have access
Can incorporation of a quantitative estimate of cortical to cerebellar SUVr as an adjunct to visual interpretation improve the accuracy and reliability of florbetapir PET scan interpretation?
Michael Pontecorvo, Michael Devous, Anupa Arora, Marybeth Devine, Ming Lu, Abhinay Joshi, Christopher Breault, Daniel Skovronsky, Mark Mintun and Stephen Heun

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 245;
You have access
A negative florbetaben PET scan reliably excludes AD pathology as confirmed by histopathology
John Seibyl, Andrew Stephens, Henryk Barthel, Kenji Ishii, Hiroyasu Akatsu, Shigeo Murayama, Christopher Rowe, Schulz-Schaefer Walter, Marwan Sabbagh and Osama Sabri

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 243;

Main menu

User menu

Search

More articles from AD II: Advanced Approaches